Supremely Important IP Decisions
It is always worth considering what can be learned about the Supreme Court’s view of IP cases when two decisions in such cases are issued on the same day.
It is always worth considering what can be learned about the Supreme Court’s view of IP cases when two decisions in such cases are issued on the same day.
This dispute should remind companies and their independent contractors of the rules regarding co-inventorship.
With the addition of Uncover’s technology, the litigation software is delivering rapid innovation.
I wish staying healthy could be cheaper.
For the purchasers of BlackBerry’s portfolio, the challenge laying ahead is an obvious one.
* Mayday mayday! Georgia prosecutor has until May 1 to respond to Trump effort to quash grand jury report. Or, in other words, Trump has inadvertently set May 1 deadline for Georgia prosecutors to level charges. [Reuters] * Hold onto your hats, but a commodity with the word "crypto" in the title might have tried to hide from legal oversight. [Bloomberg Law News] * FTC looks to make it harder for companies to ensnare consumers in difficult to leave subscriptions, which is an immensely popular move so I'm looking forward to the partisan flack this will generate. [Corporate Counsel] * When analogies go wrong: Amgen asked the Supreme Court to think of their patents more like a steam engine, prompting Thomas to quip, "It seems as though you’re actually trying to patent the use of steam pressure...." [Courthouse News Service] * "Football, but without helmets" is apparently also fraught with concussion liability. [BBC] * A dive into why representation matters when you're illegally possessing classified documents. [Salon] * Trainee lawyer diverted $100K in client insurance payments to himself to cover gambling losses. [Roll On Friday]
Facebook has had lots of luck when it comes to patents, but its luck may have just run out.
Law firms and legal departments are writing the future of the profession in separate rooms. What happens when they actually work together?
In a media briefing during the J.P. Morgan Healthcare Conference in San Francisco, Paul Hudson said unlike Sanofi, large pharma companies with top-selling drugs have a portfolio akin to a leaky bathtub because in a few years, they will have to replace much of that revenue as drug patents expire.
A look at how representation and the lack thereof shaped the career of a female patent agent turned patent lawyer.
It will be interesting to see how the impact of this decision reverberates.
The changes to Rule 7.1 disclosure have led to the recent drama roiling the patent litigation world.
LexisNexis sat down with John Ursin, Managing Partner at Schenck Price, to learn how the firm is using legal AI to strengthen client service and daily legal work.
Having litigated dozens of patent cases over the past 20 years, I thought I had seen it all, at least in terms of the variety of motions that can be presented. But I was wrong ...
Ultimately, this case is a good reminder of just how complicated big-ticket patent litigation can be.
It was interesting to see a recent decision involving the Bayh-Dole Act in a patent case involving the United States as a defendant.
Moderna is suing Pfizer and BioNTech, claiming they copied its messenger RNA work in developing their Covid-19 vaccine. The company notes that its patented work in respiratory infectious disease began years before the start of the COVID-19 pandemic, when the biotech was pursuing an mRNA vaccine for a different coronavirus.
Even the most dogged patent defendant can sometimes be defeated.